Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia

NCT01243151 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Dyslipidemia

Interventions

BIOLOGICAL: PF-04950615 (RN316)
BIOLOGICAL: PF-04950615 (RN316)
BIOLOGICAL: PF-04950615 (RN316)
BIOLOGICAL: PF-04950615 (RN316)
BIOLOGICAL: PF-04950615 (RN316)

Sponsor

Pfizer